Display Settings:

Format

Send to:

Choose Destination
    Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15768-73. Epub 2009 Aug 31.

    Generation of pluripotent stem cells from patients with type 1 diabetes.

    Source

    Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA.

    Abstract

    Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.

    PMID:
    19720998
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2735559
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Fig. 5.
    Fig. 1.
    Fig. 2.
    Fig. 4.
    Fig. 3.

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk